Clinical Trial to evaluate the effectiveness of Thoothuvalai Nei in the treatment of Eraippu Noi (Childhood Bronchial Asthma) in Children

An Open Single Arm Single Centric Phase-II Clinical Trial to evaluate the effectiveness of Thoothuvalai Nei in the treatment of Eraippu Noi (Childhood Bronchial Asthma) in Children - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/06/054507

Enrollment

Registered

2023-06-27

Start date

Unknown

Completion date

Unknown

Last updated

2024-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J452- Mild intermittent asthma Health Condition 2: J453- Mild persistent asthma Health Condition 3: J454- Moderate persistent asthma

Interventions

Intervention1: Thoothuvalai Nei: 5 ml for 5 to 7 years, 8 ml for 8 to 12 years, Once a day in the morning after food for 45 days Control Intervention1: Nil: Nil

Eligibility

Inclusion criteria

Inclusion criteria: 1.Children of both sex in the age group of 5 to 12 years with any two or more following symptoms of Cough, Wheezing, Dyspnea, Tightness of chest, Shortness of breath 2.Symptoms of Bronchial Asthma along with Peak Expiratory Flow Rate more than 50% (mild, moderate) 3.Patient informant / parent willing to sign the informed consent form

Exclusion criteria

Exclusion criteria: 1. Hemoptysis 2. Pneumonia 3. Status Asthmaticus 4. Congenital heart diseases 5. Peak expiratory flow rate less than 50%(severe exacerbation)

Design outcomes

Primary

Measure	Time frame
The outcome will be assessed using Peak Expiratory Flow Meter & PASS Score Timepoint: 45 days	—

Secondary

Measure	Time frame
NilTimepoint: Nil	—

Countries

India

Contacts

Public ContactDr A M Amala Hazel

National Institute of Siddha

dramalaaruldhas@gmail.com9486909809

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026